Dr. Jason A. Gross has been in the pharmaceutical industry for close to 20 years. Prior to joining Cipher, he was as a Venture Partner and Vice President of Scientific Affairs at MDS Capital Corporation where he served as interim management of investee companies, coordinated and conducted scientific due diligence, and provided scientific guidance to MDS Capital's investee companies. Previously, Dr. Gross was Vice President of Regulatory Affairs and Quality Assurance for DrugAbuse Sciences and had a similar role at Zenith/Goldline Pharmaceuticals. Prior to his transition into the private sector, he was an officer in the Public Health Service assigned to the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research. He served in various regulatory capacities at the FDA, including Chief Consumer Safety Officer for the Office of Generic Drugs, Division of Bioequivalence.
Dr. Gross studied marketing and management prior to receiving his Doctor of Pharmacy from the University of Arizona, after which he completed a postdoctoral specialized residency in Ambulatory Care at the National Institutes of Health.